CAN IVUS MANAGE CORONARY ARTERY INTERVENTIONS
IVUS 可以进行冠状动脉干预吗
基本信息
- 批准号:6389189
- 负责人:
- 金额:$ 33.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-02-01 至 2004-06-30
- 项目状态:已结题
- 来源:
- 关键词:angiocardioultrasonography atherosclerosis bioimaging /biomedical imaging biomechanics biomedical equipment development blood flow measurement cardiovascular imaging /visualization computer simulation coronary artery diagnosis design /evaluation diagnostic catheterization disease /disorder model elasticity histopathology image enhancement intraluminal angioplasty laboratory rabbit postmortem restenosis swine ultrasonography
项目摘要
DESCRIPTION (Adapted from Applicant's Abstract): Percutaneous interventions are
now the primary means of managing coronary artery disease, where over one
million procedures, including over 500,000 coronary stents, were performed
during 1999. Despite these advances, restenosis continues to be a major
limitation of percutaneous coronary revascularization procedures. Even in the
best cardiac catheterization labs between 10-20 percent of treated lesions must
be revascularized. Intravascular ultrasound (IVUS) is routinely used in many of
these laboratories to guide procedures. Although image quality has improved
steadily, still only about 7-8 percent of total procedures use this technology.
The primary reason for this low rate is that an IVUS study can add appreciable
time to a procedure without significantly improving the outcome. This will
change only when IVUS can efficiently guide interventions with improved
outcomes. The long range goal of this research program remains to manage nearly
every aspect of coronary artery interventions with intravascular ultrasound
(IVUS). It focuses on the common mechanical interventions of balloon
angioplasty (PCTA) and endovascular stenting. However, the methods are general
and can apply to other procedures such as ablation/vaporization and
brachytherapy. Based on progress during the initial funding period, it now
appears that IVUS can provide key information about anatomical and elastic
properties of the artery wall flow and flow dynamics within the lumen. Given
these developments, an ambitious research plan has been developed to address
how IVUS can help manage nearly every aspect of coronary artery interventions.
For the mechanical interventions of balloon angioplasty and endovascular
stenting, the applicants hypothesize that IVUS can identify the mechanical
properties of arterial lesions, guide and monitor both PCTA and stent
deployment to minimize tissue injury while insuring full stent extensions,
assess flow dynamics pre- and post-interventions, and determine the likelihood
of restenosis. In addition, an integrated IVUS delivery will be constructed to
perform mechanical interventions under full ultrasound guidance, including
real-time elasticity and flow monitoring. Such a catheter is key to optimizing
stent deployment while minimizing tissue injury and subsequent restenosis. In
addition, an integrated device can dramatically reduce the number of catheters
employed during a typical procedure.
描述(改编自申请者摘要):经皮介入治疗
现在管理冠状动脉疾病的主要手段,超过一种
进行了100万次手术,包括50多万个冠状动脉支架
在1999年。尽管取得了这些进展,再狭窄仍然是一个主要问题。
经皮冠状动脉血运重建术的局限性。即使是在
最好的心导管实验室10%-20%的治疗病变必须
进行血运重建。血管内超声(IVUS)被常规用于许多
这些实验室要指导程序。尽管图像质量有所改善
稳步地,仍然只有大约7%-8%的程序使用这项技术。
这一低比率的主要原因是静脉内超声检查可以增加可感知的
在没有显著改善结果的情况下完成手术的时间。这将是
只有当IVUS可以有效地指导干预时才进行更改
结果。这项研究计划的长期目标仍然是管理近
血管内超声冠状动脉介入治疗的方方面面
(IVUS)。重点介绍了气囊常见的机械干预
血管成形术(PCTA)和血管内支架植入。然而,这些方法是通用的。
并可应用于其他程序,如消融/汽化和
近距离放射治疗。根据最初供资期间的进展情况,现在
似乎IVUS可以提供有关解剖和弹性的关键信息
动脉壁流动的特性和管腔内的流动动力学。vt.给出
在这些发展中,已经制定了一项雄心勃勃的研究计划来解决
血管内超声如何帮助管理冠状动脉介入治疗的几乎每一个方面。
球囊血管成形术和血管内成形术的机械干预
支架置入术时,申请者假设IVUS可以识别机械性
动脉病变的性质,指导和监测经皮冠状动脉腔内成形术和支架
部署以最大限度地减少组织损伤,同时确保支架完全延长,
评估干预前后的血流动力学,并确定可能性
再狭窄的可能性。此外,还将建立一个综合的IVUS交付系统,以
在全超声引导下进行机械干预,包括
实时弹性和流量监控。这样的导管是优化
支架置入,同时将组织损伤和随后的再狭窄降至最低。在……里面
此外,一个集成的装置可以显著减少导管的数量
在一个典型的程序中使用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Matthew O'Donnell其他文献
Matthew O'Donnell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Matthew O'Donnell', 18)}}的其他基金
Real-time spectroscopic photoacoustic/ultrasound (PAUS) scanner withsimultaneous fluence and motion compensation to guide and validateinterventions: system development and preclinical testing.
实时光谱光声/超声 (PAUS) 扫描仪,具有同步注量和运动补偿功能,可指导和验证干预措施:系统开发和临床前测试。
- 批准号:
10295522 - 财政年份:2021
- 资助金额:
$ 33.29万 - 项目类别:
Real-time spectroscopic photoacoustic/ultrasound (PAUS) scanner withsimultaneous fluence and motion compensation to guide and validateinterventions: system development and preclinical testing.
实时光谱光声/超声 (PAUS) 扫描仪,具有同步注量和运动补偿功能,可指导和验证干预措施:系统开发和临床前测试。
- 批准号:
10672299 - 财政年份:2021
- 资助金额:
$ 33.29万 - 项目类别:
Non-invasive trapping and imaging of circulating tumor cells in the peripheral va
外周血管循环肿瘤细胞的无创捕获和成像
- 批准号:
8982230 - 财政年份:2012
- 资助金额:
$ 33.29万 - 项目类别:
Non-invasive trapping and imaging of circulating tumor cells in the peripheral va
外周血管循环肿瘤细胞的无创捕获和成像
- 批准号:
8416574 - 财政年份:2012
- 资助金额:
$ 33.29万 - 项目类别:
Non-invasive trapping and imaging of circulating tumor cells in the peripheral va
外周血管循环肿瘤细胞的无创捕获和成像
- 批准号:
8776296 - 财政年份:2012
- 资助金额:
$ 33.29万 - 项目类别:
Non-invasive trapping and imaging of circulating tumor cells in the peripheral va
外周血管循环肿瘤细胞的无创捕获和成像
- 批准号:
8594249 - 财政年份:2012
- 资助金额:
$ 33.29万 - 项目类别:
Optoacoustic Transduction for High-Frequency Ultrasound
高频超声的光声转换
- 批准号:
6976723 - 财政年份:2005
- 资助金额:
$ 33.29万 - 项目类别:
Ultrasonic Imaging of LIOB in Dendrimer Nanocomposites
树枝状聚合物纳米复合材料中 LIOB 的超声成像
- 批准号:
6867835 - 财政年份:2005
- 资助金额:
$ 33.29万 - 项目类别:
CATHETER ARRAY FOR MECHANICAL IMAGING OF CORONARY ARTERY
用于冠状动脉机械成像的导管阵列
- 批准号:
2332496 - 财政年份:1996
- 资助金额:
$ 33.29万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 33.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
- 批准号:
10537602 - 财政年份:2023
- 资助金额:
$ 33.29万 - 项目类别:
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
- 批准号:
2880683 - 财政年份:2023
- 资助金额:
$ 33.29万 - 项目类别:
Studentship
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
$ 33.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
- 批准号:
10652788 - 财政年份:2023
- 资助金额:
$ 33.29万 - 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
- 批准号:
10570469 - 财政年份:2023
- 资助金额:
$ 33.29万 - 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
- 批准号:
10585070 - 财政年份:2023
- 资助金额:
$ 33.29万 - 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
- 批准号:
10619831 - 财政年份:2023
- 资助金额:
$ 33.29万 - 项目类别:
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS - TOPMED
动脉粥样硬化的多种族研究 - TOPMED
- 批准号:
10974007 - 财政年份:2023
- 资助金额:
$ 33.29万 - 项目类别: